logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-25. Age distribution of all clients entering outpatient treatment by primary drug and gender, 2011 or most recent year available

Age groupOpioidsCocaineStimulantsCannabis
MaleFemaleMaleFemaleMaleFemaleMaleFemale
<150.0%0.1%0.0%0.1%0.5%1.2%3.1%5.6%
15–191.1%3.4%2.8%5.6%11.3%19.5%29.7%33.3%
20–248.4%15.4%13.3%13.7%23.9%26.1%26.3%21.9%
25–2917.6%22.3%21.0%21.3%24.7%20.5%17.2%15.1%
30–3422.4%21.2%23.4%22.0%17.6%14.3%10.5%9.5%
35–3920.0%15.2%17.6%16.3%10.4%8.1%6.0%5.9%
40–4515.8%11.2%11.7%11.1%6.3%5.6%3.8%4.4%
45 +14.6%11.3%10.2%9.9%5.4%4.7%3.4%4.4%
Total134277386624790488521242252648360016176
 

Notes:

See also 'General notes for interpreting data' on the Explanatory notes and help page.

For information on the countries supplying data and the number of treatment clients in each country see Table TDI-7.

Source:

Reitox national reports 2012 — TDI — outpatient treatment centres.

Page last updated: Friday, 26 April 2013